Table 1. The most significantly over-expressed genesa shared in comparisons of primary melanomas vs benign nevi and metastatic vs non-metastatic primary melanomas by Significance Analysis of Microarrays (SAM) (ordered by SAM score of metastatic vs non-metastatic primary melanomas).
Gene | Gene description | Probe set ID | Mean ± Sthev | Foldb | SAM Scorec | Foldb | |
---|---|---|---|---|---|---|---|
Non-metastatic primary melanomas | Metastatic primary melanomas | Metastatic vs non-metastatic | Metastatic vs non-metastatic | Melanomas vs nevi | |||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 201666_at | 1854 ± 833 | 5666 ± 2639 | 3.1 | 3.863 | 2.3 |
VCAN | Versican | 204620_s_at | 1047 ± 434 | 2466 ± 943 | 2.4 | 3.788 | 2.8 |
SPP1 | Secreted phosphoprotein 1 | 209875_s_at | 323 ± 218 | 4053 ± 3159 | 12.6 | 3.258 | 50.2 |
CTHRC1 | Collagen triple helix repeat containing 1 | 225681_at | 1307 ± 610 | 3127 ± 1450 | 2.4 | 3.240 | 4.1 |
SERPINH1 | Serpin peptidase inhibitor, clade H, member 1 | 207714_s_at | 536 ± 147 | 1114 ± 443 | 2.1 | 3.221 | 1.9 |
LGALS1 | Lectin, galactoside-binding, soluble, 1 | 201105_at | 3938 ± 1119 | 8473 ± 3897 | 2.2 | 3.144 | 1.6 |
SULF1 | Sulfatase 1 | 212354_at | 173 ± 58 | 483 ± 231 | 2.8 | 3.093 | 3.1 |
COL4A1 | Collagen, type IV, alpha 1 | 211981_at | 496 ± 222 | 953 ± 336 | 1.9 | 3.011 | 3.0 |
THY1 | Thy-1 cell surface antigen | 213869_x_at | 347 ± 116 | 659 ± 242 | 1.9 | 2.869 | 2.6 |
MME | Membrane metallo-endopeptidase | 203435_s_at | 185 ± 50 | 401 ± 165 | 2.2 | 2.825 | 2.1 |
LOC541471 / NCRNA00152 | Hypothetical LOC541471 / non-protein coding RNA 152 | 225799_at | 448 ± 237 | 1140 ± 623 | 2.5 | 2.786 | 4.7 |
C13orf18 | Chromosome 13 open reading frame 18 | 219471_at | 184 ± 74 | 363 ± 124 | 2.0 | 2.763 | 1.7 |
HEY1 | Hairy/enhancer-of-split related with YRPW motif 1 | 44783_s_at | 564 ± 353 | 1720 ± 1093 | 3.1 | 2.762 | 2.7 |
LOXL2 | Lysyl oxidase-like 2 | 202998_s_at | 211 ± 88 | 416 ± 147 | 2.0 | 2.756 | 2.0 |
IGKC | Immunoglobulin kappa constant | 221651_x_at | 2934 ± 3593 | 8942 ± 5389 | 3.0 | 2.739 | 8.4 |
A2M | Alpha-2-macroglobulin | 217757_at | 2025 ± 800 | 3437 ± 1277 | 1.7 | 2.687 | 2.8 |
ADAM12 | ADAM metallopeptidase domain 12 | 226777_at | 63 ± 35 | 283 ± 183 | 4.5 | 2.672 | 6.1 |
PARVB | Parvin, beta | 37966_at | 250 ± 78 | 490 ± 198 | 2.0 | 2.660 | 1.5 |
OLFML2B | Olfactomedin-like 2B | 213125_at | 217 ± 124 | 457 ± 190 | 2.1 | 2.600 | 2.8 |
SLC2A3 | Solute carrier family 2, member 3 | 202499_s_at | 136 ± 69 | 446 ± 285 | 3.3 | 2.594 | 3.7 |
IGHG1 / G2 / M / V4-31 | Immunoglobulin heavy constant gamma 1 / gamma 2 / mu / variable 4-31 | 211430_s_at | 2376 ± 3258 | 8114 ± 5601 | 3.4 | 2.585 | 21.7 |
ARPC1B | Actin related protein 2/3 complex, subunit 1B | 201954_at | 1341 ± 451 | 3177 ± 1927 | 2.4 | 2.566 | 2.1 |
DAB2 | Disabled homolog 2, mitogen-responsive phosphoprotein | 201279_s_at | 730 ± 401 | 1528 ± 764 | 2.1 | 2.559 | 1.9 |
NES | Nestin | 218678_at | 504 ± 251 | 1201 ± 691 | 2.4 | 2.552 | 1.6 |
RNASE1 | Ribonuclease, RNase A family, 1 (pancreatic) | 201785_at | 1494 ± 829 | 3831 ± 2434 | 2.6 | 2.551 | 2.7 |
C20orf112 | Chromosome 20 open reading frame 112 | 225224_at | 213 ± 70 | 470 ± 233 | 2.2 | 2.532 | 1.7 |
KDELR3 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 | 204017_at | 372 ± 118 | 657 ± 256 | 1.8 | 2.520 | 2.0 |
THBS1 | Thrombospondin 1 | 201108_s_at | 154 ± 48 | 274 ± 81 | 1.8 | 2.491 | 2.1 |
VSIG4 | V-set and immunoglobulin domain containing 4 | 204787_at | 187 ± 97 | 553 ± 362 | 3.0 | 2.470 | 2.1 |
SLC20A1 | Solute carrier family 20, member 1 | 201920_at | 499 ± 239 | 1208 ± 739 | 2.4 | 2.461 | 3.8 |
RRM2 | Ribonucleotide reductase M2 | 209773_s_at | 303 ± 140 | 693 ± 389 | 2.3 | 2.434 | 3.8 |
EGR1 | Early growth response 1 | 227404_s_at | 2576 ± 936 | 5552 ± 3324 | 2.2 | 2.417 | 1.9 |
TMEM158 | Transmembrane protein 158 | 213338_at | 175 ± 42 | 630 ± 484 | 3.6 | 2.405 | 2.7 |
FN1 | Fibronectin 1 | 210495_x_at | 3032 ± 1186 | 6006 ± 3292 | 2.0 | 2.402 | 2.2 |
CCL4 | Chemokine (C-C motif) ligand 4 | 204103_at | 225 ± 111 | 557 ± 338 | 2.5 | 2.360 | 3.9 |
IGKC / IGKV1-5 | Immunoglobulin kappa constant / variable 1-5 | 214836_x_at | 600 ± 548 | 1766 ± 1267 | 2.9 | 2.360 | 4.6 |
PLAUR | Plasminogen activator, urokinase receptor | 210845_s_at | 192 ± 88 | 499 ± 315 | 2.6 | 2.336 | 2.4 |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor | 203561_at | 97 ± 54 | 490 ± 425 | 5.1 | 2.333 | 4.9 |
CALU | Calumenin | 200755_s_at | 702 ± 231 | 1251 ± 591 | 1.8 | 2.317 | 2.0 |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | 209714_s_at | 157 ± 57 | 291 ± 109 | 1.9 | 2.313 | 3.0 |
SH2B3 | SH2B adaptor protein 3 | 203320_at | 287 ± 145 | 593 ± 307 | 2.1 | 2.306 | 2.3 |
RAB20 | RAB20, member RAS oncogene family | 219622_at | 198 ± 64 | 562 ± 395 | 2.8 | 2.297 | 1.9 |
ATP6V0E2 | ATPase, H+ transporting V0 subunit e2 | 213587_s_at | 340 ± 92 | 751 ± 457 | 2.2 | 2.272 | 1.8 |
IGLC7 / IGLV1-44 | Immunoglobulin lambda constant 7 / variable 1-44 | 215379_x_at | 655 ± 752 | 2434 ± 2071 | 3.7 | 2.266 | 11.6 |
PLA2G16 | Phospholipase A2, group XVI | 209581_at | 219 ± 145 | 408 ± 152 | 1.9 | 2.244 | 2.9 |
GRB10 | Growth factor receptor-bound protein 10 | 209409_at | 217 ± 76 | 463 ± 257 | 2.1 | 2.234 | 1.8 |
IGLV1-44 / LOC100290481 | Immunoglobulin lambda variable 1-44 / immunoglobulin lambda light chain-like | 214677_x_at | 1483 ± 1970 | 5704 ± 5106 | 3.8 | 2.196 | 19.4 |
CYR61 | Cysteine-rich, angiogenic inducer, 61 | 201289_at | 350 ± 93 | 740 ± 451 | 2.1 | 2.179 | 3.3 |
PCOLCE | Procollagen C-endopeptidase enhancer | 202465_at | 726 ± 289 | 1332 ± 712 | 1.8 | 2.142 | 2.1 |
CHN1 | Chimerin (chimaerin) 1 | 212624_s_at | 247 ± 101 | 457 ± 216 | 1.8 | 2.130 | 2.8 |
PAPSS2 | 3′-phosphoadenosine 5′-phosphosulfate synthase 2 | 203058_s_at | 159 ± 74 | 335 ± 180 | 2.1 | 2.113 | 2.6 |
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor | 210992_x_at | 225 ± 90 | 582 ± 427 | 2.6 | 2.095 | 2.0 |
MCAM | Melanoma cell adhesion molecule | 209086_x_at | 326 ± 62 | 649 ± 387 | 2.0 | 2.079 | 1.6 |
CCL2 | Chemokine (C-C motif) ligand 2 | 216598_s_at | 385 ± 206 | 1346 ± 1242 | 3.5 | 2.076 | 4.6 |
CCR1 | Chemokine (C-C motif) receptor 1 | 205099_s_at | 109 ± 74 | 391 ± 333 | 3.6 | 2.064 | 4.0 |
SLC2A14 / SLC2A3 | Solute carrier family 2, member 14 / solute carrier family 2, member 3 | 216236_s_at | 272 ± 71 | 536 ± 311 | 2.0 | 2.050 | 1.8 |
FKBP11 | FK506 binding protein 11 | 219118_at | 269 ± 119 | 605 ± 404 | 2.2 | 2.047 | 3.0 |
BCL2A1 | BCL2-related protein A1 | 205681_at | 292 ± 306 | 682 ± 424 | 2.3 | 2.047 | 3.6 |
IGLL3P | Immunoglobulin lambda-like polypeptide 3, pseudogene | 215946_x_at | 175 ± 104 | 446 ± 317 | 2.5 | 2.038 | 2.8 |
BST2 | Bone marrow stromal cell antigen 2 | 201641_at | 297 ± 145 | 660 ± 440 | 2.2 | 2.037 | 2.2 |
EMILIN2 | Elastin microfibril interfacer 2 | 224374_s_at | 272 ± 136 | 593 ± 382 | 2.2 | 2.034 | 1.8 |
Only annotated genes and the first probe set for each gene are shown. Full gene list is available by request.
Genes with ≥2-fold change at least in one of the comparisons are shown.
The FDR q-value for each was <0.001.